Tilray: Canaccord Cuts Price Target To $12 After Q1 Results
On October 7, Tilray Inc (TSX: TLRY) reported their first quarter financial results for the period ending August 31st, 2021.
Read more
Tilray
Tilray Sees Haywood Slash Price Target To $12.50
On October 7, Tilray Inc (TSX: TLRY) reported their first quarter financial results for the period ending August 31, 2021.
Read more
Tilray Posts Q1 Revenues Of US$168.0 Million, Net Loss Of $34.6 Million
Tilray Inc (TSX: TLRY) this morning reported its first quarter financial results for the period ended August 31, 2021. The
Read more
Cannabis Companies Have Begun Moving To Self-Insure
There is a common expression in the cannabis industry that “everything is more expensive.” Even in markets where the industry
Read more
Tilray: Haywood Expects Canadian Market Share To Drop In First Quarter
Tilray Inc (TSX: TLRY) (NASDAQ: TLRY) announced that they would be reporting their Fiscal first-quarter results of 2021 on October
Read more
Medmen Posts Q4 Loss Of $46.2 Million
Medmen Enterprises (CSE: MMEN) last night reminded investors why Canaccord Genuity had a long standing $0.00 price target on the
Read more
Tilray: Cantor Lowers Price Target, Walks Back Coca-Cola Comments
Last week, Cantor Fitzgerald updated their estimates on a bundle of Canadian License Producers. In every case, they slashed the
Read more
Tilray Sees Gotham Green Look To Sell Recently Acquired Shares
It appears that Gotham Green Partners has approximately zero interest in being a shareholder of Tilray Inc (TSX: TLRY) (NASDAQ:
Read more
Democrats Take Aim At “Big Cannabis” In Proposed CAOC Legislation
It appears that the federal legalization of cannabis in the United States might not be in the best interest of
Read more
Tilray: Analysts Leave Targets Unchanged After MedMen Investment
On August 17, Tilray (NASDAQ: TLRY) made the announcement that they formed a new limited partnership with other strategic investors,
Read more